SmartVascular™ Test: Revolutionizing Vascular Risk Assessment Nationwide

SmartVascular™ Test: Revolutionizing Vascular Risk Assessment Nationwide IRVINE, Calif., June 11, 2025 (GLOBE NEWSWIRE) — MorningStar Laboratories, LLC (“MSL” or “the Company”), a leading developer of precision diagnostic tests that address unmet clinical needs, proudly announces its SmartVascular Dx™ (SVDx) test (formally known as the PULS Cardiac test), designed to transform the early detection and management […]